A grouped bar chart showing the number of biotech drugs in the pipeline in December 2025 (in blue) and December 2024 (in yellow) in the US, Europe, China, California, Massachusetts, Japan, New York, New Jersey, Maryland, Pennsylvania, Texas, and North Carolina. The label for Massachusetts is bolded, and is shown between California and Japan.